High Integrity, energetic CEO and Board MemberExpertise in leading private and public companies including IPOOperational Leader with broad experience from drug development to commercialization across a wide range of therapeutic areas________________________________________Results-driven Public and Private biotech Chief Executive Officer | CEO | President | Board Member | with over 16 years of experience leading companies and over 30 years in commercial and research/drug development. Proven track record in operational success, financial acumen with over $225M raised, and strong relationships with Boards of Directors and institutional investors. Passionate about innovation and committed to fostering strong, high-performing cultures.________________________________________Key StrengthsStrategic Vision: Proven ability to lead organizations through critical growth phases and execute strategic initiatives with precision.Financial Acumen: Raised over $225M in financing, including a highly successful $92M NASDAQ IPO, and establishing strong relationships with top-tier institutional investors and sell-side analysts.Operational Leadership: Demonstrated success in founding and growing biotech companies from pre-clinical to Phase 3 studies, expanding team to over 70 employees, and cultivating enduring employee engagement. Over career, launched or re-launched 6 commercial products in hospital and orphan disease-focused therapeutics.Board and Investor Relations: Exceptional skills in building and maintaining trusting relationships with Boards of Directors, institutional investors, and key financial stakeholders.________________________________________Specialties: Orphan products, CNS, GI, Auto Immune, Commercial Development, Oncology, Immunotherapy (I/O), and HIV products